Skip to main content
PRO MEDICUS LIMITED logo

PRO MEDICUS LIMITED — Investor Relations & Filings

Ticker · PME ISIN · AU000000PME8 LEI · 98450085A903D1BMFF27 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2024-10-15 Capital/Financing Update
Country AU Australia
Listing ASX PME

About PRO MEDICUS LIMITED

https://www.promed.com.au

Pro Medicus Limited provides advanced healthcare imaging software and enterprise-wide IT solutions. The company’s core offering is the Visage 7 platform, which employs server-side rendering technology to enable rapid, high-resolution streaming of medical images, including MRI, CT, and X-ray data. Its product suite encompasses diagnostic viewing, vendor-neutral archiving, and clinical workflow management. Designed for large-scale health systems and academic medical centers, the technology supports cloud-based deployments and integrates artificial intelligence to streamline diagnostic processes. The platform focuses on performance and scalability, allowing clinicians to access and interpret complex imaging datasets from multiple locations without the need for local data transfer.

Recent filings

Filing Released Lang Actions
PME signs $32M, 5-year contract extension in Australia 2 pages 179.1KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement about a contract extension worth $32 million over 5 years with a large Australian Radiology Network. It highlights the contract details and includes quotes from the CEO. There is no financial report, no detailed financial statements, no regulatory filing references, or any mention of annual or quarterly results. The document is short (2320 characters) and is clearly an announcement of a business development or capital/contract update. This fits best under Capital/Financing Update (CAP) as it relates to a significant contract extension impacting company revenue streams.
2024-10-15 English
AGM Date 1 page 308.2KB
AGM Information Classification · 100% confidence The document is a short announcement dated 08 October 2024 from Pro Medicus Limited regarding the date and details of its 2024 Annual General Meeting (AGM). It specifies the meeting date, location, and nomination deadline for director elections. There is no financial data, no detailed report, and no mention of attached reports or filings. The content is clearly about providing information related to the AGM event itself, not the full AGM materials or minutes. Therefore, this fits the category of AGM Information (AGM-R). The document length is short (1095 characters), consistent with an announcement rather than a full report.
2024-10-07 English
PME signs A$98M, 8 year contract renewal with Mercy Health 2 pages 178.6KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement about a contract renewal worth $98 million over 8 years with Mercy Health. It focuses on the details of the contract renewal, including terms and financial value, but does not contain any financial statements, quarterly or annual results, nor does it mention any regulatory filings or report publications. It is a specific update on a capital/financing activity related to contract revenue and business operations. The document length is short (2895 characters) and it is clearly an announcement rather than a full report or transcript. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-10-06 English
Change of Director's Interest Notice - Anthony Hall 3 pages 447.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director's Interest Notice' and references Listing Rule 3.19A.2 and section 205G of the Corporations Act, which relate to disclosures of directors' shareholdings and transactions. It details the director's name, date of last notice, nature of securities held, number of shares disposed and acquired, and the nature of the transaction (off-market transfer). There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure of insider share transactions by a director. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and content confirm it is not a brief announcement or a report publication notice but a full disclosure notice. Therefore, the correct classification is DIRS with high confidence.
2024-09-12 English
Application for quotation of securities - PME 5 pages 16.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used for the application for quotation of securities. It details the transfer of securities previously issued under an employee incentive scheme where restrictions on transfer have ceased. The document includes specifics about the securities to be quoted, their class, number, and issue dates. It is not a financial report, earnings release, or management discussion but rather an official announcement related to securities quotation and capital changes. This fits the category of Share Issue/Capital Change (SHA). The document length is about 4986 characters, and it is a full announcement, not just a brief notice or a report publication announcement.
2024-08-25 English
Notification of cessation of securities - PME 4 pages 14.6KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Pro Medicus Limited. It provides specific information about the securities that have ceased, the reason for cessation, and the updated issued capital. The document is a regulatory announcement related to changes in the company's issued securities, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial data. The document length is 3799 characters, which is relatively short and focused on a specific securities cessation event. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about securities changes that does not fit into more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS), since it concerns cessation of securities due to lapse of rights rather than issuance or buyback. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-08-25 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.